Rajesh K Jain, | |
5841 S Maryland Ave, Chicago, IL 60637-1443 | |
(888) 824-0200 | |
Not Available |
Full Name | Rajesh K Jain |
---|---|
Gender | Male |
Speciality | Endocrinology |
Experience | 12 Years |
Location | 5841 S Maryland Ave, Chicago, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083976187 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 036137463 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The University Of Chicago Medical Center | Chicago, IL | Hospital |
Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The University Of Chicago Medical Center | 7618880766 | 754 |
University Of Chicago | 7719899426 | 1137 |
News Archive
A geocoding approach - linking routinely collected public health data to neighborhood socioeconomic factors - shows consistently higher rates of COVID-19 illness and death among people living in more-disadvantaged communities, reports a study in the November/December Journal of Public Health Management and Practice.
H3 Biomedicine today announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a comprehensive approach to breakthrough oncology treatments based on two primary principles: 1) the genetics of patients' cancers can reveal drug targets tailored to their cancers and 2) the advances in modern chemistry enable the discovery of new classes of safe and effective drugs against these targets.
An intestinal patch device containing insulin that can be swallowed in the form of a capsule, in development by researchers at University of California Santa Barbara, has demonstrated efficacy of blood glucose management in diabetic rats. This work is being presented Oct. 27 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.
The life-threatening African trypanosomiasis, also called sleeping sickness, is caused by protozoa of the species Trypanosoma brucei. A team at the Biocentre of the Julius-Maximilians-Universität Würzburg in Bavaria, Germany, studies the pathogens and has now reported exciting news: The trypanosomes have a so far unknown enzyme which does not exist in humans and other vertebrates. This makes it a promising target for therapy.
The most deadly global health crisis in a century has resulted in a substantial decline in overall heart surgery volume and an unexplained increase in deaths after coronary artery bypass grafting, according to late-breaking research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.
› Verified 1 days ago
Entity Name | University Of Chicago |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821048786 PECOS PAC ID: 7719899426 Enrollment ID: O20031103000094 |
News Archive
A geocoding approach - linking routinely collected public health data to neighborhood socioeconomic factors - shows consistently higher rates of COVID-19 illness and death among people living in more-disadvantaged communities, reports a study in the November/December Journal of Public Health Management and Practice.
H3 Biomedicine today announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a comprehensive approach to breakthrough oncology treatments based on two primary principles: 1) the genetics of patients' cancers can reveal drug targets tailored to their cancers and 2) the advances in modern chemistry enable the discovery of new classes of safe and effective drugs against these targets.
An intestinal patch device containing insulin that can be swallowed in the form of a capsule, in development by researchers at University of California Santa Barbara, has demonstrated efficacy of blood glucose management in diabetic rats. This work is being presented Oct. 27 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.
The life-threatening African trypanosomiasis, also called sleeping sickness, is caused by protozoa of the species Trypanosoma brucei. A team at the Biocentre of the Julius-Maximilians-Universität Würzburg in Bavaria, Germany, studies the pathogens and has now reported exciting news: The trypanosomes have a so far unknown enzyme which does not exist in humans and other vertebrates. This makes it a promising target for therapy.
The most deadly global health crisis in a century has resulted in a substantial decline in overall heart surgery volume and an unexplained increase in deaths after coronary artery bypass grafting, according to late-breaking research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.
› Verified 1 days ago
Entity Name | The University Of Chicago Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033218128 PECOS PAC ID: 7618880766 Enrollment ID: O20031106000203 |
News Archive
A geocoding approach - linking routinely collected public health data to neighborhood socioeconomic factors - shows consistently higher rates of COVID-19 illness and death among people living in more-disadvantaged communities, reports a study in the November/December Journal of Public Health Management and Practice.
H3 Biomedicine today announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a comprehensive approach to breakthrough oncology treatments based on two primary principles: 1) the genetics of patients' cancers can reveal drug targets tailored to their cancers and 2) the advances in modern chemistry enable the discovery of new classes of safe and effective drugs against these targets.
An intestinal patch device containing insulin that can be swallowed in the form of a capsule, in development by researchers at University of California Santa Barbara, has demonstrated efficacy of blood glucose management in diabetic rats. This work is being presented Oct. 27 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.
The life-threatening African trypanosomiasis, also called sleeping sickness, is caused by protozoa of the species Trypanosoma brucei. A team at the Biocentre of the Julius-Maximilians-Universität Würzburg in Bavaria, Germany, studies the pathogens and has now reported exciting news: The trypanosomes have a so far unknown enzyme which does not exist in humans and other vertebrates. This makes it a promising target for therapy.
The most deadly global health crisis in a century has resulted in a substantial decline in overall heart surgery volume and an unexplained increase in deaths after coronary artery bypass grafting, according to late-breaking research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Rajesh K Jain, 150 Harvester Dr, Suite 300, Burr Ridge, IL 60527-5919 Ph: () - | Rajesh K Jain, 5841 S Maryland Ave, Chicago, IL 60637-1443 Ph: (888) 824-0200 |
News Archive
A geocoding approach - linking routinely collected public health data to neighborhood socioeconomic factors - shows consistently higher rates of COVID-19 illness and death among people living in more-disadvantaged communities, reports a study in the November/December Journal of Public Health Management and Practice.
H3 Biomedicine today announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a comprehensive approach to breakthrough oncology treatments based on two primary principles: 1) the genetics of patients' cancers can reveal drug targets tailored to their cancers and 2) the advances in modern chemistry enable the discovery of new classes of safe and effective drugs against these targets.
An intestinal patch device containing insulin that can be swallowed in the form of a capsule, in development by researchers at University of California Santa Barbara, has demonstrated efficacy of blood glucose management in diabetic rats. This work is being presented Oct. 27 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.
The life-threatening African trypanosomiasis, also called sleeping sickness, is caused by protozoa of the species Trypanosoma brucei. A team at the Biocentre of the Julius-Maximilians-Universität Würzburg in Bavaria, Germany, studies the pathogens and has now reported exciting news: The trypanosomes have a so far unknown enzyme which does not exist in humans and other vertebrates. This makes it a promising target for therapy.
The most deadly global health crisis in a century has resulted in a substantial decline in overall heart surgery volume and an unexplained increase in deaths after coronary artery bypass grafting, according to late-breaking research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.
› Verified 1 days ago
Dr. Sorin C Danciu, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3134 N Clark St, Chicago, IL 60657 Phone: 773-880-9722 | |
Anoopa A. Koshy, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611 Phone: 312-926-6000 | |
William Edmond Gerardi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613 Phone: 773-244-3060 | |
Suparna Dutta, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612 Phone: 312-942-4200 Fax: 312-942-3568 | |
Alexandra Dumitrescu, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Mitesh Mahesh Kabadi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612 Phone: 312-942-5020 | |
Dr. Marta Batus, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612 Phone: 312-563-2487 Fax: 312-942-3192 |